Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

George N Okoli

Showing results (1-10 of 53) with videos related to

Pageof 6
Sort By:
Drugs|August 21, 2024
Influenza Vaccine Effectiveness and Progress Towards a Universal Influenza VaccineBenjamin J Cowling, George N Okoli
The Journal of Infectious Diseases|October 15, 2024
Improved Methods for Vaccine Effectiveness StudiesGeorge N Okoli, Benjamin J Cowling
Annals of Family Medicine|July 22, 2024
Nirmatrelvir/Ritonavir Regimen for Mild/Moderately Severe COVID-19: A Rapid Review With Meta-Analysis and Trial Sequential AnalysisGeorge N Okoli, Nicole Askin, Rasheda Rabbani
Clinical Drug Investigation|November 25, 2025
Treatment of Non-severe COVID-19 with Molnupiravir: A Systematic Review with Meta-analysis and Trial Sequential Analysis of the Evidence from Randomized Controlled TrialsGeorge N Okoli, Nicole Askin, Rasheda Rabbani
Scandinavian Journal of Public Health|June 3, 2022
Correlation between country-level numbers of COVID-19 cases and mortalities, and country-level characteristics: A global studyGeorge N Okoli, Christine J Neilson, Ahmed M Abou-Setta
European Journal of Anaesthesiology|May 27, 2016
Reply to: association of preoperative cardiovascular drugs with short-term mortality after coronary artery bypass graftingRobert D Sanders, Sudhir Venkatesan, George N Okoli, et al.
Clinical Drug Investigation|July 3, 2026
Effectiveness of the Approved Nirmatrelvir/Ritonavir and Molnupiravir Regimens for Treatment of Mild/Moderate Laboratory-Confirmed SARS-CoV-2 Infection in Patients Aged 18-64 Years in Hong Kong: A Population-Based Cohort StudyGeorge N Okoli, Yun Lin, Peng Wu, et al.
Open Forum Infectious Diseases|July 25, 2020
Variations in Seasonal Influenza Vaccine Effectiveness due to Study Characteristics: A Systematic Review and Meta-analysis of Test-Negative Design StudiesGeorge N Okoli, Florentin Racovitan, Christiaan H Righolt, et al.
Infection|December 5, 2023
A global systematic evidence review with meta-analysis of the epidemiological characteristics of the 2022 Mpox outbreaksGeorge N Okoli, Paul Van Caeseele, Nicole Askin, et al.
Infectious Diseases (London, England)|May 18, 2023
Comparative evaluation of the clinical presentation and epidemiology of the 2022 and previous Mpox outbreaks: a rapid review and meta-analysisGeorge N Okoli, Paul Van Caeseele, Nicole Askin, et al.
Pageof 6

Showing results (1-10 of 53) with videos related to

Sort By:
Pageof 6
Drugs|August 21, 2024
Influenza Vaccine Effectiveness and Progress Towards a Universal Influenza VaccineBenjamin J Cowling, George N Okoli
The Journal of Infectious Diseases|October 15, 2024
Improved Methods for Vaccine Effectiveness StudiesGeorge N Okoli, Benjamin J Cowling
Annals of Family Medicine|July 22, 2024
Nirmatrelvir/Ritonavir Regimen for Mild/Moderately Severe COVID-19: A Rapid Review With Meta-Analysis and Trial Sequential AnalysisGeorge N Okoli, Nicole Askin, Rasheda Rabbani
Clinical Drug Investigation|November 25, 2025
Treatment of Non-severe COVID-19 with Molnupiravir: A Systematic Review with Meta-analysis and Trial Sequential Analysis of the Evidence from Randomized Controlled TrialsGeorge N Okoli, Nicole Askin, Rasheda Rabbani
Scandinavian Journal of Public Health|June 3, 2022
Correlation between country-level numbers of COVID-19 cases and mortalities, and country-level characteristics: A global studyGeorge N Okoli, Christine J Neilson, Ahmed M Abou-Setta
European Journal of Anaesthesiology|May 27, 2016
Reply to: association of preoperative cardiovascular drugs with short-term mortality after coronary artery bypass graftingRobert D Sanders, Sudhir Venkatesan, George N Okoli, et al.
Clinical Drug Investigation|July 3, 2026
Effectiveness of the Approved Nirmatrelvir/Ritonavir and Molnupiravir Regimens for Treatment of Mild/Moderate Laboratory-Confirmed SARS-CoV-2 Infection in Patients Aged 18-64 Years in Hong Kong: A Population-Based Cohort StudyGeorge N Okoli, Yun Lin, Peng Wu, et al.
Open Forum Infectious Diseases|July 25, 2020
Variations in Seasonal Influenza Vaccine Effectiveness due to Study Characteristics: A Systematic Review and Meta-analysis of Test-Negative Design StudiesGeorge N Okoli, Florentin Racovitan, Christiaan H Righolt, et al.
Infection|December 5, 2023
A global systematic evidence review with meta-analysis of the epidemiological characteristics of the 2022 Mpox outbreaksGeorge N Okoli, Paul Van Caeseele, Nicole Askin, et al.
Infectious Diseases (London, England)|May 18, 2023
Comparative evaluation of the clinical presentation and epidemiology of the 2022 and previous Mpox outbreaks: a rapid review and meta-analysisGeorge N Okoli, Paul Van Caeseele, Nicole Askin, et al.
Pageof 6